Skip to content

Research and Development of High-Throughput Mass Spectrometry Technology Based on Nanomaterials for Clinical Applications in Tumors

Research and Development of High-Throughput Mass Spectrometry Technology Based on Nanomaterials for Clinical Applications in Tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074763
Enrollment
Unknown
Registered
2023-08-15
Start date
2020-01-01
Completion date
Unknown
Last updated
2023-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Gold Standard:1. Colonoscopy pathological diagnosis report
2. Radiology diagnostic report.
Index test:Serum peptide fingerprinting

Sponsors

The second Affiliated Hospital, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range is 18-80 years, gender unrestricted; 2. Newly diagnosed patients without prior treatment for colorectal cancer/polyps (including surgical treatment, chemotherapy, radiation therapy, targeted therapy, immunotherapy, interventional therapy, etc.); 3. Complete and traceable clinical data; 4. Age and gender match between patients with colorectal cancer, patients with benign intestinal lesions, and the healthy population.

Exclusion criteria

Exclusion criteria: 1. History of previous tumors exists; 2. Unable to obtain imaging or pathological data, making it impossible to determine the benign or malignant classification.

Design outcomes

Primary

MeasureTime frame
Serum circulating peptides;Diagnostic model sensitivity;Diagnostic model specificity;

Secondary

MeasureTime frame
Serum tumor markers;

Countries

China

Contacts

Public ContactJiekai Yu

The Second Affiliated Hospital Zhejiang University School of Medicine

yjk@zju.edu.cn+86 135 7571 0380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026